Advertisement

Topics

Pharma execs weigh in on possible changes under Trump

11:26 EST 1 Dec 2016 | Reuters

(Reuters) - The top executives at two of the largest U.S. drugmakers weighed in on Thursday for the first time on possible changes for the industry next year under U.S. President-elect Donald Trump.

Original Article: Pharma execs weigh in on possible changes under Trump

NEXT ARTICLE

More From BioPortfolio on "Pharma execs weigh in on possible changes under Trump"

Quick Search
Advertisement